MMCAP International’s Translational Development Acquisition Corp Units TDACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-350,000
Closed -$3.62M – 187
2025
Q2
$3.62M Hold
350,000
– – 0.44% 46
2025
Q1
$3.55M Hold
350,000
– – 0.6% 33
2024
Q4
$3.51M Buy
+350,000
New +$3.51M 0.53% 37

Other funds holding TDACU

MMCAP International's TDACU Position: Q3 2025 in Review

MMCAP International sold out of Translational Development Acquisition Corp Units (TDACU) in Q3 2025, closing a stake of 350,000 shares — an estimated $3.62M sold.

MMCAP International first reported a position in TDACU in Q4 2024 and held it in 3 quarters. The position peaked at $3.62M in Q2 2025. 7 funds tracked by Wall St. Rank hold TDACU as of Q3 2025.

  • MMCAP International reported no remaining Translational Development Acquisition Corp Units position as of Q3 2025 after selling out during the quarter.
  • MMCAP International sold 350,000 Translational Development Acquisition Corp Units shares in Q3 2025, an estimated $3.62M.
  • MMCAP International first reported a position in Translational Development Acquisition Corp Units in Q4 2024 and held it in 3 quarters.
  • MMCAP International's Translational Development Acquisition Corp Units position peaked at $3.62M in Q2 2025.
  • 7 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Units as of Q3 2025.

Based on MMCAP International's 13F filing for Q3 2025, filed 10 Nov 2025.